Jaguar Health (JAGX) Goodwill (2017 - 2018)
Jaguar Health (JAGX) posted quarterly Goodwill of $5.2 million for Q4 2018, little changed year-over-year from $5.2 million in Q4 2017, and little changed quarter-over-quarter from $5.2 million in Q3 2018.
Jaguar Health (JAGX) Goodwill (2017 - 2018) Analysis & Trends
Jaguar Health (JAGX) has reported Goodwill for 2 consecutive years, with $5.2 million the latest figure, recorded in Q4 2018.
- In Q4 2018, Goodwill changed 0.0% year-over-year to $5.2 million; the TTM figure through Dec 2018 stood at $5.2 million (changed 0.0% YoY), while the FY2018 annual figure was $5.2 million, changed 0.0% from the prior year.
- Goodwill was little changed at $5.2 million in Q4 2018 per JAGX's latest filing, from $5.2 million in the prior quarter.
- Across five years, Goodwill topped out at $18.4 million in Q3 2017 and bottomed at $5.2 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.41 Bn | 130.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.41 Bn | 59.23 Bn | 1.37 Bn |
| 4 | Moderna | 57.56 Bn | 52.43 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.06 Bn | 36.96 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.95 Bn | 27.65 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.48 Bn | 9.09 Bn | 668.28 Mn |
| 8 | Insmed | 27.31 Bn | 26.15 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.04 Bn | 26.20 Bn | - |
| 10 | Jaguar Health | 459,051.31 | -9.60 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 5.21 Mn |
| Sep 30, 2018 | 5.21 Mn |
| Jun 30, 2018 | 5.21 Mn |
| Mar 31, 2018 | 5.21 Mn |
| Dec 31, 2017 | 5.21 Mn |
| Sep 30, 2017 | 18.39 Mn |